Gender and Drug Use Discrimination Among People Who Inject Drugs: An Intersectional Approach Using the COSINUS Cohort

References

• Seear K. Addressing alcohol and other drug stigma: where to next? Drug Alcohol Rev. 2020;39(2):109–113. doi:10.1111/dar.13028
   PubMed Web of Science ®Google Scholar
• Earnshaw VA, Chaudoir SR. From conceptualizing to measuring HIV stigma: a review of HIV stigma mechanism measures. AIDS Behav. 2009;13(6):1160–1177. doi:10.1007/s10461-009-9593-3
   PubMed Web of Science ®Google Scholar
• Muncan B, Walters SM, Ezell J, Ompad DC. “They look at us like junkies”: influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City. Harm Reduct J. 2020;17(1):53. doi:10.1186/s12954-020-00399-8
   PubMed Web of Science ®Google Scholar
• Biancarelli DL, Biello KB, Childs E, et al. Strategies used by people who inject drugs to avoid stigma in healthcare settings. Drug Alcohol Depend. 2019;198:80–86. doi:10.1016/j.drugalcdep.2019.01.037
   PubMed Web of Science ®Google Scholar
• Couto E, Cruz C, Salom C, Maravilla J, Alati R. Mental and physical health correlates of discrimination against people who inject drugs: a systematic review. J Stud Alcohol Drugs. 2018;79(3):350–360. doi:10.15288/jsad.2018.79.350
   PubMed Web of Science ®Google Scholar
• Paquette CE, Syvertsen JL, Pollini RA. Stigma at every turn: health services experiences among people who inject drugs. Int J Drug Policy. 2018;57:104–110. doi:10.1016/j.drugpo.2018.04.004
   PubMed Web of Science ®Google Scholar
• Meyers SA, Earnshaw VA, D’Ambrosio B, Courchesne N, Werb D, Smith LR. The intersection of gender and drug use-related stigma: a mixed methods systematic review and synthesis of the literature. Drug Alcohol Depend. 2021;223:108706. doi:10.1016/j.drugalcdep.2021.108706
   PubMed Web of Science ®Google Scholar
• Cadet-Taïrou A, Janssen É, Guilbaud F. Profils et pratiques des usagers reçus en CAARUD en 2019. Tendances. 2020;142:4.
   Google Scholar
• Brener L, Cama E, Broady T, et al. Experiences of stigma and subsequent reduced access to health care among women who inject drugs. Drug Alcohol Rev. 2024. doi:10.1111/dar.13806
   Web of Science ®Google Scholar
• Iversen J, Page K, Madden A, Maher L. HIV, HCV and health-related harms among women who inject drugs: implications for prevention and treatment. J Acquir Immune Defic Syndr. 2015;69(1):S176–S181. doi:10.1097/QAI.0000000000000659
   PubMedGoogle Scholar
• Degenhardt L, Peacock A, Colledge S, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health. 2017;5(12):e1192–e1207. doi:10.1016/S2214-109X(17)30375-3
   PubMed Web of Science ®Google Scholar
• Observatoire français des drogues et des tendances addictives [Drugs and Addictions, Key Data 2022]. Drogues et addictions, chiffres clés 2022 - 9e édition; 2022: 8.
   Google Scholar
• Auriacombe M, Roux P, Briand Madrid L, et al. Impact of drug consumption rooms on risk practices and access to care in people who inject drugs in France: the COSINUS prospective cohort study protocol. BMJ Open. 2019;9(2):e023683. doi:10.1136/bmjopen-2018-023683
   PubMed Web of Science ®Google Scholar
• Roux P, Jauffret-Roustide M, Donadille C, et al. Impact of drug consumption rooms on non-fatal overdoses, abscesses and emergency department visits in people who inject drugs in France: results from the COSINUS cohort. Int J Epidemiol. 2022:dyac120. doi:10.1093/ije/dyac120
   Web of Science ®Google Scholar
• Lalanne L, Roux P, Donadille C, et al. Drug consumption rooms are effective to reduce at-risk practices associated with HIV/HCV infections among people who inject drugs: results from the COSINUS cohort study. Addict Abingdon Engl. 2024;119(1):180–199. doi:10.1111/add.16320
   PubMedGoogle Scholar
• Medina-Perucha L, Scott J, Chapman S, Barnett J, Dack C, Family H. A qualitative study on intersectional stigma and sexual health among women on opioid substitution treatment in England: implications for research, policy and practice. Soc Sci Med. 2019;222:315–322. doi:10.1016/j.socscimed.2019.01.022
   PubMed Web of Science ®Google Scholar
• Ayon S, Ndimbii J, Jeneby F, et al. Barriers and facilitators of access to HIV, harm reduction and sexual and reproductive health services by women who inject drugs: role of community-based outreach and drop-in centers. AIDS Care. 2018;30(4):480–487. doi:10.1080/09540121.2017.1394965
   PubMed Web of Science ®Google Scholar
• Värmå Falk M, Strömdahl S, Ekström AM, et al. A qualitative study of facilitators and barriers to participate in a needle exchange program for women who inject drugs. Harm Reduction Journal. 2020;17(1):84. doi:10.1186/s12954-020-00425-9
   PubMed Web of Science ®Google Scholar
• Shirley-Beavan S, Roig A, Burke-Shyne N, Daniels C, Csak R. Women and barriers to harm reduction services: a literature review and initial findings from a qualitative study in Barcelona, Spain. Harm Reduct J. 2020;17(1):1–13. doi:10.1186/s12954-020-00429-5
   PubMed Web of Science ®Google Scholar
• Schmitt F. L’accès des femmes aux CAARUD: une discrimination négative indirecte. In: Espaces genrés des drogues: parcours dans l’intimité, la fête et la réduction des risques. Le Bord de l’eau. 2022: 71–98. Available from: https://shs.hal.science/halshs-03664595. Accessed February 7, 2024.
   Google Scholar
• Fédération bruxelloise des Institutions pour Toxicomanes. Femmes* Genre et Assuétudes - Synthèse Des Constats de Terrain et Recommandations de La FEDITO BXL; 2023: 35.
   Google Scholar
• Gupta GR, Oomman N, Grown C, et al. Gender equality and gender norms: framing the opportunities for health. Lancet Lond Engl. 2019;393(10190):2550–2562. doi:10.1016/S0140-6736(19)30651-8
   PubMed Web of Science ®Google Scholar
• Boyd J, Lavalley J, Czechaczek S et al. “Bed Bugs and Beyond”: an ethnographic analysis of North America’s first women-only supervised drug consumption site [Female-oriented programmes in addiction care: Results from the Ad-femina survey]. Int J Drug Policy. 2020;78:102733. doi:10.1016/j.drugpo.2020.102733
   PubMed Web of Science ®Google Scholar
• Mutatayi C. Résultats de l’enquête Ad-femina: accueil spécifique des femmes en addictologie [Female-oriented programmes in addiction care: Results from the Ad-femina survey]. Tendances. 2019;130:6.
   Google Scholar
• Rhodes T. The ‘risk environment’: a framework for understanding and reducing drug-related harm. Int J Drug Policy. 2002;13(2):85–94. doi:10.1016/S0955-3959(02)00007-5
   Google Scholar
• Couto E, Cruz C, Salom CL, et al. Frequent experience of discrimination among people who inject drugs: links with health and wellbeing. Drug Alcohol Depend. 2018;190:188–194. doi:10.1016/j.drugalcdep.2018.06.009
   PubMed Web of Science ®Google Scholar
• Larney S, Peacock A, Mathers BM, Hickman M, Degenhardt L. A systematic review of injecting-related injury and disease among people who inject drugs. Drug Alcohol Depend. 2017;171:39–49. doi:10.1016/j.drugalcdep.2016.11.029
   PubMed Web of Science ®Google Scholar
• Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend. 1998;51(3):253–263. doi:10.1016/S0376-8716(98)00028-3
   PubMed Web of Science ®Google Scholar
• Else-Quest NM, Hyde JS. Intersectionality in quantitative psychological research: ii. methods and techniques. Psychol Women Q. 2016;40(3):319–336. doi:10.1177/0361684316647953
   Web of Science ®Google Scholar